JPRN-UMIN000047159已完成未知
Trends in allogeneic hematopoietic cell transplantation for adult ALL over the past three decades - Trends in allo-HCT for ALL over the three decades
agoya University Hospital0 个研究点目标入组 8,467 人开始时间: 2022年3月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 8,467
研究概览
简要总结
Allo-HCT outcomes for adults with ALL have improved over the past 30 years. Non-relapse mortality was improved regardless of Philadelphia chromosome (Ph) status and disease status. Although there were continual improvements in adjusted survival for Ph-positive patients, the improvement was inadequate for Ph- patients with t(4;11), t(8;14), t(14;18), or hypodiploidy.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not agree to participate in this study
研究者
相似试验
已完成
不适用
Allogeneic Stem Cell Transplantation (ALLO-SCT) in Elderly: 17-years Retrospective GITMO SurveyAllogeneic Stem Cell Transplantation in Elderly PatientsNCT04469985Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia2,061
已完成
2 期
Allogeneic Hematopoietic Stem Cell Transplantation Using a Non-myeloablative Preparative Regimen of Total Lymphoid Irradiation and Anti-thymocyte Globulin for Older Patients With Relapsed Lymphoid MalignanciesHaemato-lymphoid Malignancies or Syndromes in Whom Allogeneic Stem Cell Transplantation is WarrantedNCT01566656Nantes University Hospital15
尚未招募
不适用
AlloLife - Life After TransplantationSurvivorshipStem Cell Transplant ComplicationsNCT05087784University Hospital, Essen192
终止
不适用
RElapse After Allograft: Link Between LoCus of Control and QualiTy of LifeAllograftPost-allograft RelapseNCT05258929Centre Hospitalier Universitaire de Saint Etienne3
已完成
2 期
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous LeukemiaAcute Myelogenous LeukemiaNCT00623935University of Michigan Rogel Cancer Center56